180 related articles for article (PubMed ID: 11279282)
1. Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals.
von Coelln R; Kügler S; Bähr M; Weller M; Dichgans J; Schulz JB
J Neurochem; 2001 Apr; 77(1):263-73. PubMed ID: 11279282
[TBL] [Abstract][Full Text] [Related]
2. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
Bilsland J; Roy S; Xanthoudakis S; Nicholson DW; Han Y; Grimm E; Hefti F; Harper SJ
J Neurosci; 2002 Apr; 22(7):2637-49. PubMed ID: 11923429
[TBL] [Abstract][Full Text] [Related]
3. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment.
Han BS; Hong HS; Choi WS; Markelonis GJ; Oh TH; Oh YJ
J Neurosci; 2003 Jun; 23(12):5069-78. PubMed ID: 12832530
[TBL] [Abstract][Full Text] [Related]
4. A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson's disease models.
Kanthasamy AG; Anantharam V; Zhang D; Latchoumycandane C; Jin H; Kaul S; Kanthasamy A
Free Radic Biol Med; 2006 Nov; 41(10):1578-89. PubMed ID: 17045926
[TBL] [Abstract][Full Text] [Related]
5. p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly.
Izumi Y; Sawada H; Sakka N; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A
J Neurosci Res; 2005 Mar; 79(6):849-60. PubMed ID: 15712215
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
7. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.
Hurelbrink CB; Armstrong RJ; Luheshi LM; Dunnett SB; Rosser AE; Barker RA
Exp Neurol; 2001 Sep; 171(1):46-58. PubMed ID: 11520120
[TBL] [Abstract][Full Text] [Related]
8. Reassessment of caspase inhibition to augment grafted dopamine neuron survival.
Marchionini DM; Collier TJ; Pitzer MR; Sortwell CE
Cell Transplant; 2004; 13(3):273-82. PubMed ID: 15191165
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons.
Choi WS; Eom DS; Han BS; Kim WK; Han BH; Choi EJ; Oh TH; Markelonis GJ; Cho JW; Oh YJ
J Biol Chem; 2004 May; 279(19):20451-60. PubMed ID: 14993216
[TBL] [Abstract][Full Text] [Related]
10. Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons.
Dodel RC; Du Y; Bales KR; Ling ZD; Carvey PM; Paul SM
Neuroscience; 1998 Oct; 86(3):701-7. PubMed ID: 9692710
[TBL] [Abstract][Full Text] [Related]
11. Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration.
Cutillas B; Espejo M; Gil J; Ferrer I; Ambrosio S
Neuroreport; 1999 Aug; 10(12):2605-8. PubMed ID: 10574377
[TBL] [Abstract][Full Text] [Related]
12. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.
Viswanath V; Wu Y; Boonplueang R; Chen S; Stevenson FF; Yantiri F; Yang L; Beal MF; Andersen JK
J Neurosci; 2001 Dec; 21(24):9519-28. PubMed ID: 11739563
[TBL] [Abstract][Full Text] [Related]
13. Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK.
Choi WS; Yoon SY; Oh TH; Choi EJ; O'Malley KL; Oh YJ
J Neurosci Res; 1999 Jul; 57(1):86-94. PubMed ID: 10397638
[TBL] [Abstract][Full Text] [Related]
14. Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration.
Kitazawa M; Anantharam V; Kanthasamy AG
Neuroscience; 2003; 119(4):945-64. PubMed ID: 12831855
[TBL] [Abstract][Full Text] [Related]
15. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Eberhardt O; Coelln RV; Kugler S; Lindenau J; Rathke-Hartlieb S; Gerhardt E; Haid S; Isenmann S; Gravel C; Srinivasan A; Bahr M; Weller M; Dichgans J; Schulz JB
J Neurosci; 2000 Dec; 20(24):9126-34. PubMed ID: 11124990
[TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons.
Lotharius J; Dugan LL; O'Malley KL
J Neurosci; 1999 Feb; 19(4):1284-93. PubMed ID: 9952406
[TBL] [Abstract][Full Text] [Related]
17. Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death.
Dodel RC; Du Y; Bales KR; Ling Z; Carvey PM; Paul SM
Brain Res Mol Brain Res; 1999 Jan; 64(1):141-8. PubMed ID: 9889353
[TBL] [Abstract][Full Text] [Related]
18. The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons.
Ahmadi FA; Linseman DA; Grammatopoulos TN; Jones SM; Bouchard RJ; Freed CR; Heidenreich KA; Zawada WM
J Neurochem; 2003 Nov; 87(4):914-21. PubMed ID: 14622122
[TBL] [Abstract][Full Text] [Related]
19. Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells.
Ochu EE; Rothwell NJ; Waters CM
J Neurochem; 1998 Jun; 70(6):2637-40. PubMed ID: 9603231
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin X promotes 6-hydroxydopamine-induced apoptosis of PC12 and SH-SY5Y cells.
Pišlar AH; Zidar N; Kikelj D; Kos J
Neuropharmacology; 2014 Jul; 82():121-31. PubMed ID: 23958447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
